FDA Compliance Basics For Biotech PR And Marketing Communications
More than 90 percent of FDA warning letters issued to drug and biologic manufacturers include concerns about promotional communications. That statistic alone should make any PR or marketing leader pause. In biotech, communication is never just storytelling. It sits at the intersection of science, regulation, and public trust. If you work in biotech PR or … Read more